MeSH term
Count | Dimethyl Sulfoxide/*pharmacology | 25 |
Dimethyl Sulfoxide/pharmacology | 92 |
Dimethyl Sulfoxide/metabolism/pharmacology | 1 |
Dimethyl Sulfoxide/*analogs & derivatives/*pharmacology | 1 |
Dimethyl Sulfoxide/*analogs & derivatives/pharmacology/therapeutic use | 1 |
Dimethyl Sulfoxide | 14 |
Dimethyl Sulfoxide/metabolism | 2 |
Dimethyl Sulfoxide/toxicity | 1 |
Dimethyl Sulfoxide/therapeutic use | 1 |
Dimethyl Sulfoxide/administration & dosage | 2 |
Dimethyl Sulfoxide/metabolism/toxicity | 1 |
9,10-Dimethyl-1,2-benzanthracene/*pharmacology | 3 |
9,10-Dimethyl-1,2-benzanthracene/pharmacology | 8 |
9,10-Dimethyl-1,2-benzanthracene/metabolism/*pharmacology | 2 |
9,10-Dimethyl-1,2-benzanthracene/pharmacokinetics/*pharmacology | 1 |
9,10-Dimethyl-1,2-benzanthracene | 15 |
Dimethyl Suberimidate/*chemistry | 1 |
9,10-Dimethyl-1,2-benzanthracene/toxicity | 6 |
9,10-Dimethyl-1,2-benzanthracene/pharmacokinetics | 2 |
9,10-Dimethyl-1,2-benzanthracene/*toxicity | 6 |
9,10-Dimethyl-1,2-benzanthracene/metabolism | 5 |
9,10-Dimethyl-1,2-benzanthracene/*pharmacokinetics | 1 |
9,10-Dimethyl-1,2-benzanthracene/*metabolism | 1 |
9,10-Dimethyl-1,2-benzanthracene/metabolism/toxicity | 1 |
9,10-Dimethyl-1,2-benzanthracene/*pharmacokinetics/*toxicity | 1 |
9,10-Dimethyl-1,2-benzanthracene/pharmacokinetics/toxicity | 1 |
9,10-Dimethyl-1,2-benzanthracene/*analogs & derivatives | 1 |
9,10-Dimethyl-1,2-benzanthracene/analogs & derivatives/*metabolism | 1 |
9,10-Dimethyl-1,2-benzanthracene/chemistry/metabolism/pharmacokinetics | 1 |
DNA/pharmacology | 7 |
MSH/*pharmacology | 3 |
DDT/pharmacology | 1 |
RNA/*pharmacology | 3 |
RNA/pharmacology | 4 |
SRS-A/pharmacology | 7 |
*Pharmacology | 4 |
MSH/pharmacology | 6 |
Tin/*pharmacology | 1 |
NAD/pharmacology | 14 |
NAD/*pharmacology | 5 |
DDT/*pharmacology | 4 |
DNA/*pharmacology | 3 |
Pharmacology | 4 |
Bromelains/*pharmacology | 5 |
Dimethylformamide/pharmacology | 2 |
Batroxobin/pharmacology | 1 |
Tyramine/pharmacology | 3 |
Ferricyanides/*pharmacology | 3 |
Valerates/pharmacology | 3 |
DNA, Antisense/*pharmacology | 13 |
Sulfoxides/pharmacology | 6 |
Porphobilinogen/pharmacology | 1 |
Furazolidone/*pharmacology | 1 |
Lactates/*pharmacology | 1 |
Cinnamates/*pharmacology | 9 |
Formates/pharmacology | 1 |
Ondansetron/*pharmacology | 1 |
Levonorgestrel/*pharmacology | 5 |
Gallium/*pharmacology | 2 |
Arbaprostil/*pharmacology | 1 |
Aminophenols/pharmacology | 3 |
Caerulein/*pharmacology | 3 |
Alcohols/pharmacology | 4 |
Deoxyglucose/pharmacology | 20 |
Fibrinogen/pharmacology | 15 |
Oxalates/*pharmacology | 1 |
Interleukin-5/*pharmacology | 32 |
Matrilysin/*pharmacology | 1 |
Glucosamine/*pharmacology | 2 |
Ribavirin/pharmacology | 4 |
Ephrin-A1/pharmacology | 1 |
Thrombospondin 1/pharmacology | 3 |
Arsenic/*pharmacology | 4 |
Phenylephrine/*pharmacology | 4 |
Arsenites/pharmacology | 19 |
Malondialdehyde/*pharmacology | 4 |
Tetraisopropylpyrophosphamide/pharmacology | 3 |
Dioxins/*pharmacology | 14 |
Aspartame/*pharmacology | 1 |
Phosphorylcholine/*pharmacology | 1 |
Hypoxanthine/pharmacology | 3 |
Cyproterone/pharmacology | 3 |
Thrombospondins/*pharmacology | 2 |
Phencyclidine/pharmacology | 1 |
Ethidium/*pharmacology | 1 |
Cobalt/*pharmacology | 10 |
Lipoproteins, HDL/pharmacology | 15 |
Polytetrafluoroethylene/*pharmacology | 1 |
Ketamine/pharmacology | 3 |
Apolipoproteins B/*pharmacology | 3 |
Receptors, Fc/pharmacology | 1 |
Thymosin/pharmacology | 2 |
Insecticides/*pharmacology | 11 |
Carrageenan/pharmacology | 4 |
Triazenes/*pharmacology | 1 |
Trifluoperazine/*pharmacology | 38 |
Mercaptoethanol/*pharmacology | 5 |
Beryllium/pharmacology | 2 |
Fluorides/pharmacology | 28 |
Tetracycline/*pharmacology | 18 |
